参考文献（下滑查看）：
[1]LeynaertB, NeukirchF, DemolyP, et al. Epidemiologic evidence for asthma and rhinitis comorbidity[J]. J Allergy Clin Immunol, 2000, 106(5Suppl):S201-S205. DOI: 10.1067/mai.2000.110151.
[2]GrossmanJ. One airway, one disease[J]. Chest, 1997, 111(2Suppl):11S-16S. DOI: 10.1378/chest.111.2_supplement.11s.
[3]Giavina-BianchiP, AunMV, TakejimaP, et al. United airway disease: current perspectives[J]. J Asthma Allergy, 2016, 9:93-100. DOI: 10.2147/JAA.S81541.
[4]Paiva FerreiraL, Paiva FerreiraL, MonteiroTM, et al. Combined allergic rhinitis and asthma syndrome (CARAS)[J]. Int Immunopharmacol, 2019, 74:105718. DOI: 10.1016/j.intimp.2019.105718.
[5]HongML, SongY, LiXM. Effects and mechanisms of actions of Chinese herbal medicines for asthma[J]. Chin J Integr Med, 2011, 17(7):483-491. DOI: 10.1007/s11655-011-0780-5.
[6]JongbloedWM, BrownSM. Allergies and natural alternatives[J]. Otolaryngol Clin North Am, 2022, 55(5):965-982. DOI: 10.1016/j.otc.2022.06.005.
[7]BrożekJL, BousquetJean, AgacheIoana, et al. Allergic rhinitis and its impact on asthma(ARIA) guidelines 2016 revision[J]. J Allergy Clin Immunol. 2017, 140(4):950-958. DOI: 10.1016/j.jaci.2017.03.050.
[8]陈耀龙, 杨克虎, 王小钦, 等. 中国制订/修订临床诊疗指南的指导原则(2022版)[J]. 中华医学杂志, 2022, 102(10):697-703. DOI: 10.3760/cma.j.cn112137-20211228-02911.
[9]PachecoSE, Guidos-FogelbachG, Annesi-MaesanoI, et al. Climate change and global issues in allergy and immunology[J]. J Allergy Clin Immunol, 2021, 148(6):1366-1377. DOI: 10.1016/j.jaci.2021.10.011.
[10]中华医学会变态反应分会呼吸过敏学组(筹), 中华医学会呼吸病学分会哮喘学组. 中国过敏性哮喘诊治指南(第一版, 2019年)[J]. 中华内科杂志, 2019, 58(9):636-655. DOI: 10.3760/cma.j.issn.0578?1426.2019.09.004.
[11]中国妇幼保健协会儿童变态反应专业委员会, 《中国实用儿科杂志》编辑委员会. 儿童变应性鼻炎-哮喘综合征中西医结合诊治专家共识(2023)[J].中国实用儿科杂志,2023,38(3):168-176.DOI: 10.19538/j.ek2023030602.
[12]汪红莉, 陈莉娜. 上-下气道疾病联合管理的生理和免疫基础[J]. 中国实用儿科杂志, 2022, 37(9):660-663. DOI: 10.19538/j.ek2022090604.
[13]CompalatiE, RidoloE, PassalacquaG, et al. The link between allergic rhinitis and asthma: the united airways disease[J]. Expert Rev Clin Immunol, 2010, 6(3):413-423. DOI: 10.1586/eci.10.15.
[14]AghasafariP, GeorgeU, PidapartiR. A review of inflammatory mechanism in airway diseases[J]. Inflamm Res, 2019, 68(1):59-74. DOI: 10.1007/s00011-018-1191-2.
[15]中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 中国变应性鼻炎诊断和治疗指南(2022年,修订版)[J]. 中华耳鼻咽喉头颈外科杂志, 2022, 57(2):106-129. DOI: 10.3760/cma.j.cn115330-20211228-00828.
[16]FengCH, MillerMD, SimonRA. The united allergic airway: connections between allergic rhinitis, asthma, and chronic sinusitis[J]. Am J Rhinol Allergy, 2012, 26(3):187-190. DOI: 10.2500/ajra.2012.26.3762.
[17]YanZ, LiuL, JiaoL, et al. Bioinformatics analysis and identification of underlying biomarkers potentially linking allergic rhinitis and asthma[J]. Med Sci Monit, 2020, 26:e924934. DOI: 10.12659/MSM.924934.
[18]WeiY, ZhangZ, WangF, et al. Assessment of tumor growth factor-β1 neutralizing antibody in the treatment of allergic rhinitis and asthma[J]. Exp Ther Med, 2018, 15(1):649-656. DOI: 10.3892/etm.2017.5501.
[19]CingiC, MulukNB, CobanogluB, et al. Nasobronchial interaction[J]. World J Clin Cases, 2015, 3(6):499-503. DOI: 10.12998/wjcc.v3.i6.499.
[20]中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南(2020年版)[J]. 中华结核和呼吸杂志, 2020, 43(12):1023-1048. DOI: 10.3760/cma.j.cn112147-20200618-00721.
[21]ChenH, LiJ, ChengL, et al. China consensus document on allergy diagnostics[J]. Allergy Asthma Immunol Res, 2021, 13(2):177-205. DOI: 10.4168/aair.2021.13.2.177.
[22]BousquetJ, HeinzerlingL, BachertC, et al. Practical guide to skin prick tests in allergy to aeroallergens[J]. Allergy, 2012, 67(1):18-24. DOI: 10.1111/j.1398-9995.2011.02728.x.
[23]北京医学会过敏变态反应学分会. 过敏原皮肤点刺试验的专家共识[J]. 北京医学, 2020, 42(10):1-20. DOI: 10.15932/j.0253-9713.2020.10.912.
[24]HuangR, QinR, HuQ, et al. Effect of Dermatophagoides pteronyssinus Immunotherapy on Upper and Lower Airway Eosinophilic Inflammatory Response to Nasal Allergen Challenge[J]. Allergy Asthma Immunol Res, 2020, 12(5):844-858. DOI: 10.4168/aair.2020.12.5.844.
[25]ZhuZ, WangH, XieY, et al. Response of upper and lower airway inflammation to bronchial challenge with house dust mite in Chinese asthmatics: a pilot study[J]. J Thorac Dis, 2021, 13(8):4988-4998. DOI: 10.21037/jtd-20-2876.
[26]徐荣, 朱政, 王红玉, 等. 变应原吸入激发试验应用概况[J]. 国际呼吸杂志, 2017, 37(7):547-552. DOI: 10.3760/cma.j.issn.1673-436X.2017.07.014.
[27]OttavianoG, FokkensWJ. Measurements of nasal airflow and patency: a critical review with emphasis on the use of peak nasal inspiratory flow in daily practice[J]. Allergy, 2016, 71(2):162-174. DOI: 10.1111/all.12778.
[28]LuoW, ChenQ, ChenR, et al. Reference value of induced sputum cell counts and its relationship with age in healthy adults in Guangzhou, Southern China[J]. Clin Respir J, 2018, 12(3):1160-1165. DOI: 10.1111/crj.12645.
[29]中国医药教育协会慢性气道疾病专业委员会, 中国哮喘联盟. 呼出气一氧化氮检测及其在气道疾病诊治中应用的中国专家共识[J]. 中华医学杂志, 2021, 101(38):3092-3114. DOI: 10.3760/cma.j.cn112137-20210210-00408.
[30]BrożekJL, BousquetJ, AgacheI, et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines-2016 revision[J]. J Allergy Clin Immunol, 2017, 140(4):950-958. DOI: 10.1016/j.jaci.2017.03.050.
[31]张珒珒,崔宴文,高亚东. 变应性鼻炎合并气道高反应性的风险因素研究进展[J]. 临床耳鼻咽喉头颈外科杂志, 2023, 37(6):457-462. DOI: 10.13201/j.issn.2096-7993.2023.06.010.
[32]Todo-BomA, BraidoF, MolinengoG, et al. The Portuguese version of Rhinitis and Asthma Patient′s Perspective (RAPP): validation and assessment[J]. Pulmonology, 2020, 26(2):73-77. DOI: 10.1016/j.pulmoe.2018.10.009.
[33]YasuoM, KitaguchiY, KomatsuY, et al. Self-assessment of allergic rhinitis and asthma (SACRA) questionnaire-based allergic rhinitis treatment improves asthma control in asthmatic patients with allergic rhinitis[J]. Intern Med, 2017, 56(1):31-39. DOI: 10.2169/internalmedicine.56.7251.
[34]KatsimprisP, TripsianisG, PrintzaA, et al. The rhinoconjunctivitis quality of life questionnaire and its modified short version validation in adults and children with allergic rhinitis[J]. J Laryngol Otol, 2022, 136(4):341-348. DOI: 10.1017/S0022215121004011.
[35]BatemanED, EsserD, ChirilaC, et al. Magnitude of effect of asthma treatments on asthma quality of life questionnaire and asthma control questionnaire scores: systematic review and network meta-analysis[J]. J Allergy Clin Immunol, 2015, 136(4):914-922. DOI: 10.1016/j.jaci.2015.03.023.
[36]LohiaS, SchlosserRJ, SolerZM. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis[J]. Allergy, 2013, 68(5):569-579. DOI: 10.1111/all.12124.
[37]Global Initiative for Asthma. Global strategy for asthma management and prevention[EB/OL].[2023-10-25]. https://ginasthma.org/.
[38]国家呼吸系统疾病临床医学研究中心, 中华医学会儿科学分会呼吸学组哮喘协作组, 中国医药教育协会儿科专业委员会, 等. 奥马珠单抗在儿童过敏性哮喘临床应用专家共识[J]. 中华实用儿科临床杂志, 2021, 36(12):881-890. DOI: 10.3760/cma.j.cn101070-20210531-00621.
[39]PelaiaG, GallelliL, RendaT, et al. Update on optimal use of omalizumab in management of asthma[J]. J Asthma Allergy, 2011, 4:49-59. DOI: 10.2147/JAA.S14520.
[40]BeckLA, MarcotteGV, MacGlashanD, et al. Omalizumab-induced reductions in mast cell Fce psilon RI expression and function[J]. J Allergy Clin Immunol, 2004, 114(3):527-530. DOI: 10.1016/j.jaci.2004.06.032.
[41]KangJ, LiJ, KongL, et al.Relationship between omalizumab efficacy and baseline allergen profile impacts patient-reported outcomes in allergic asthma[C]//ERS International Congress 2018 abstracts.2018.DOI: 10.1183/13993003.congress-2018.PA3956.
[42]MayRD, FungM. Strategies targeting the IL-4/IL-13 axes in disease[J]. Cytokine, 2015, 75(1):89-116. DOI: 10.1016/j.cyto.2015.05.018.
[43]DhariwalJ, CameronA, Trujillo-TorralboMB, et al. Mucosal type 2 innate lymphoid cells are a key component of the allergic response to aeroallergens[J]. Am J Respir Crit Care Med, 2017, 195(12):1586-1596. DOI: 10.1164/rccm.201609-1846OC.
[44]SwainSL, WeinbergAD, EnglishM, et al. IL-4 directs the development of Th2-like helper effectors[J]. J Immunol, 1990, 145(11):3796-3806.
[45]KopfM, Le GrosG, BachmannM, et al. Disruption of the murine IL-4 gene blocks Th2 cytokine responses[J]. Nature, 1993, 362(6417):245-248. DOI: 10.1038/362245a0.
[46]McLeodJJ, BakerB, RyanJJ. Mast cell production and response to IL-4 and IL-13[J]. Cytokine, 2015, 75(1):57-61. DOI: 10.1016/j.cyto.2015.05.019.
[47]RaelEL, LockeyRF. Interleukin-13 signaling and its role in asthma[J]. World Allergy Organ J, 2011, 4(3):54-64. DOI: 10.1097/WOX.0b013e31821188e0.
[48]GourN, Wills-KarpM. IL-4 and IL-13 signaling in allergic airway disease[J]. Cytokine, 2015, 75(1):68-78. DOI: 10.1016/j.cyto.2015.05.014.
[49]WenzelS, CastroM, CorrenJ, et al. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial[J]. Lancet, 2016, 388(10039):31-44. DOI: 10.1016/S0140-6736(16)30307-5.
[50]WeinsteinSF, KatialR, JayawardenaS, et al. Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma[J]. J Allergy Clin Immunol, 2018, 142(1):171-177.e1. DOI: 10.1016/j.jaci.2017.11.051.
[51]CastroM, CorrenJ, PavordID, et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma[J]. N Engl J Med, 2018, 378(26):2486-2496. DOI: 10.1056/NEJMoa1804092.
[52]BusseWW, MasperoJF, LuY, et al. Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis[J]. Ann Allergy Asthma Immunol, 2020, 125(5):565-576.e1. DOI: 10.1016/j.anai.2020.05.026.
[53]中华医学会呼吸病学分会哮喘学组, 中国哮喘联盟. 重症哮喘诊断与处理中国专家共识[J]. 中华结核和呼吸杂志, 2017, 40(11):813-829. DOI: 10.3760/cma.j.issn.1001-0939.2017.11.006.
[54]BrusselleGG, KoppelmanGH. Biologic therapies for severe asthma[J]. N Engl J Med, 2022, 386(2):157-171. DOI: 10.1056/NEJMra2032506.
[55]KuriharaM, KabataH, IrieM, et al. Current summary of clinical studies on anti-TSLP antibody, Tezepelumab, in asthma[J]. Allergol Int, 2023, 72(1):24-30. DOI: 10.1016/j.alit.2022.11.006.
[56]Menzies-GowA, CorrenJ, BourdinA, et al. Tezepelumab in adults and adolescents with severe, uncontrolled asthma[J]. N Engl J Med, 2021, 384(19):1800-1809. DOI: 10.1056/NEJMoa2034975.
[57]DurhamSR, YangWH, PedersenMR, et al. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis[J]. J Allergy Clin Immunol, 2006, 117(4):802-809. DOI: 10.1016/j.jaci.2005.12.1358.
[58]VirchowJC, BackerV, KunaP, et al. Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: a randomized clinical trial[J]. JAMA, 2016, 315(16):1715-1725. DOI: 10.1001/jama.2016.3964.
[59]FritzschingB, ContoliM, PorsbjergC, et al. Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: results from the REACT study, a retrospective cohort study[J]. Lancet Reg Health Eur, 2022, 13:100275. DOI: 10.1016/j.lanepe.2021.100275.
[60]KoppMV, HamelmannE, ZielenS, et al. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma[J]. Clin Exp Allergy, 2009, 39(2):271-279.DOI: 10.1111/j.1365-2222.2008.03121.x.
[61]MassanariM, NelsonH, CasaleT, et al. Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma[J]. J Allergy Clin Immunol, 2010, 125(2):383-389. DOI: 10.1016/j.jaci.2009.11.022.
[62]中华医学会呼吸病学分会哮喘学组. 奥马珠单抗治疗过敏性哮喘的中国专家共识(2021版)[J]. 中华结核和呼吸杂志, 2022, 45(4):341-354. DOI: 10.3760/cma.j.cn112147-20220115-00051.
[63]中华中医药学会肺系病分会. 支气管哮喘中医诊疗专家共识(2012)[J].中医杂志, 2013, 54(7):627-629.
[64]张洪春. 中医临床诊疗指南释义·呼吸病分册[M]. 北京:中国中医药出版社,2015.
[65]田道法. 中西医结合耳鼻喉科学[M]. 北京:中国中医药出版社,2001.
[66]国家药典委员会. 中华人民共和国药典(一部)[M]. 北京:中国医药科技出版社,2020.
[67]张洪春. 中成药临床应用指南·呼吸系统疾病分册[M]. 北京:中国中医药出版社,2016.
[68]中华人民共和国国家卫生健康委员会. 国家基本药物目录(2018年版)[EB/OL] [2023-07-19].http://www.gov.cn/zhengce/zhengceku/2018-12/31/5435470/files/5802d337476e4953b0e9f388a6309f9a.pdf.
[69]王洪田, 王学艳. 变应性鼻炎防治中应重视环境控制和加强健康教育[J]. 中华预防医学杂志, 2023, 57(3):318-326. DOI: 10.3760/cma.j.cn112150-20221103-01058.
[70]Eguiluz-GraciaI, MathioudakisAG, BartelS, et al. The need for clean air: the way air pollution and climate change affect allergic rhinitis and asthma[J]. Allergy, 2020, 75(9):2170-2184. DOI: 10.1111/all.14177.
[71]章如新, 郭志强. PM2.5与变应性鼻炎[J]. 中国耳鼻咽喉颅底外科杂志, 2017, 23(1): 1-4.
[72]WangJ, JansonC, JogiR, et al. A prospective study on the role of smoking, environmental tobacco smoke, indoor painting and living in old or new buildings on asthma, rhinitis and respiratory symptoms[J]. Environ Res, 2021, 192:110269. DOI: 10.1016/j.envres.2020.110269.
[73]HaahtelaT, HolgateS, PawankarR, et al. The biodiversity hypothesis and allergic disease: world allergy organization position statement[J]. World Allergy Organ J, 2013, 6(1):3. DOI: 10.1186/1939-4551-6-3.
[74]VerduciE, MartelliA, MinielloVL, et al. Nutrition in the first 1 000 days and respiratory health: a descriptive review of the last five years′ literature[J]. Allergol Immunopathol (Madr), 2017, 45(4):405-413. DOI: 10.1016/j.aller.2017.01.003.
[75]FornoE, YoungOM, KumarR, et al. Maternal obesity in pregnancy, gestational weight gain, and risk of childhood asthma[J]. Pediatrics, 2014, 134(2):e535-e546. DOI: 10.1542/peds.2014-0439.
[76]NurmatovU, DevereuxG, SheikhA. Nutrients and foods for the primary prevention of asthma and allergy: systematic review and meta-analysis[J]. J Allergy Clin Immunol, 2011, 127(3):724-733.e1-e30. DOI: 10.1016/j.jaci.2010.11.001.
[77]BrewBK, AllenCW, ToelleBG, et al. Systematic review and meta-analysis investigating breast feeding and childhood wheezing illness[J]. Paediatr Perinat Epidemiol, 2011, 25(6):507-518. DOI: 10.1111/j.1365-3016.2011.01233.x.
[78]Cuello-GarciaCA, FiocchiA, PawankarR, et al. World Allergy Organization-McMaster University guidelines for allergic disease prevention (GLAD-P): Prebiotics[J]. World Allergy Organ J, 2016, 9:10. DOI: 10.1186/s40413-016-0102-7.
[79]MulderB, Schuiling-VeningaCC, BosHJ, et al. Prenatal exposure to acid-suppressive drugs and the risk of allergic diseases in the offspring: a cohort study[J]. Clin Exp Allergy, 2014, 44(2):261-269. DOI: 10.1111/cea.12227.
[80]LinYC, ChenYC, KuoCH, et al. Antibiotic exposure and asthma development in children with allergic rhinitis[J]. J Microbiol Immunol Infect, 2020, 53(5):803-811. DOI: 10.1016/j.jmii.2019.02.003.
[81]MarraF, MarraCA, RichardsonK, et al. Antibiotic use in children is associated with increased risk of asthma[J]. Pediatrics, 2009, 123(3):1003-1010. DOI: 10.1542/peds.2008-1146.
[82]StensballeLG, SimonsenJ, JensenSM, et al. Use of antibiotics during pregnancy increases the risk of asthma in early childhood[J]. J Pediatr, 2013, 162(4):832-838.e3. DOI: 10.1016/j.jpeds.2012.09.049.
[83]CheeloM, LodgeCJ, DharmageSC, et al. Paracetamol exposure in pregnancy and early childhood and development of childhood asthma: a systematic review and meta-analysis[J]. Arch Dis Child, 2015, 100(1):81-89. DOI: 10.1136/archdischild-2012-303043.
[84]EyersS, WeatherallM, JefferiesS, et al. Paracetamol in pregnancy and the risk of wheezing in offspring: a systematic review and meta-analysis[J]. Clin Exp Allergy, 2011, 41(4):482-489. DOI: 10.1111/j.1365-2222.2010.03691.x.
[85]BozekA, JarzabJ, BednarskiP. The effect of allergen-specific immunotherapy on offspring[J]. Allergy Asthma Proc, 2016, 37(4):59-63. DOI: 10.2500/aap.2016.37.3960.
[86]叶远航, 向浏岚, 罗富锟, 等. 变应性鼻炎患者心理特征的研究进展[J]. 中国现代医学杂志, 2021, 31(12):51-56. DOI: 10.3969/j.issn.1005-8982.2021.12.010.
[87]FlaniganC, SheikhA, DunnGalvinA, et al. Prenatal maternal psychosocial stress and offspring′s asthma and allergic disease: a systematic review and meta-analysis[J]. Clin Exp Allergy, 2018, 48(4):403-414. DOI: 10.1111/cea.13091.
[88]北京医学会过敏变态反应学分会. 过敏性疾病诊治和预防专家共识(Ⅲ)[J]. 中华预防医学杂志, 2022, 56(12):1685-1693. DOI: 10.3760/cma.j.cn112150-20220209-00118.
[89]HeadK, SnidvongsK, GlewS, et al. Saline irrigation for allergic rhinitis[J]. Cochrane Database Syst Rev, 2018, 6(6):CD012597. DOI: 10.1002/14651858.CD012597.pub2.
[90]WangY, JinL, LiuSX, et al. Role of nasal saline irrigation in the treatment of allergic rhinitis in children and adults: a systematic analysis[J]. Allergol Immunopathol (Madr), 2020, 48(4):360-367. DOI: 10.1016/j.aller.2020.01.002.
